en

PRODUCT DETAIL

Thiotepa Riemser 15 mg prášok na koncentrát na infúzny roztok

Code 7356D
MA number EU/1/21/1536/001
Product Form: plc ifc 1x15 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01A ALKYLATING AGENTS
L01AC Ethylene imines
L01AC01 Thiotepa
Shelf life: 18
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 26.03.2021
Validity: 26.03.2026
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 26.02.2024
eu-flag.png sk-flag.png